Advertisement
Screener

DARLING INGREDIENTS INC. (DAR) Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net

2.4 / 5 stars · 57/120 Roast Me

DARLING INGREDIENTS INC. Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net

DARLING INGREDIENTS INC. (DAR) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of -$1.75 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.

Discontinued › Income Statement › Other Income

us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2018-05-09

  • DARLING INGREDIENTS INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2018-03-31 was -$1.75M, a 2084.09% decline year-over-year.
  • DARLING INGREDIENTS INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-09-30 was $1.69M, a 422.91% increase year-over-year.
  • DARLING INGREDIENTS INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-07-01 was -$1.39M, a 960.49% decline year-over-year.
  • DARLING INGREDIENTS INC. derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-04-01 was $88.00K, a 69.23% increase year-over-year.
Period endDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 monthDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 monthDerivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month
2018-03-31-$1.75M
10-Q · filed 2018-05-09
2017-09-30$1.69M
10-Q · filed 2017-11-07
$295.00K
derived: sum of 2 quarters · filed 2017-11-07
$384.00K
10-Q · filed 2017-11-07
2017-07-01-$1.39M
10-Q · filed 2017-08-09
-$1.30M
10-Q · filed 2017-08-09
2017-04-01$88.00K
10-Q · filed 2018-05-09
2016-10-01$323.00K
10-Q · filed 2017-11-07
$485.00K
derived: sum of 2 quarters · filed 2017-11-07
$537.00K
10-Q · filed 2017-11-07
2016-07-02$162.00K
10-Q · filed 2017-08-09
$214.00K
10-Q · filed 2017-08-09
2016-04-02$52.00K
10-Q · filed 2017-05-11
2015-10-03$1.21M
10-Q · filed 2016-11-10
$534.00K
derived: sum of 2 quarters · filed 2016-11-10
$479.00K
10-Q · filed 2016-11-10
2015-07-04-$672.00K
10-Q · filed 2016-08-11
-$727.00K
10-Q · filed 2016-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Bunge Global SA (BG)Switzerland$21.391B36.03
Archer-Daniels-Midland Co (ADM)United States$39.458B20.81